Literature DB >> 24937429

TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration.

Chun-Chi Liang, Lauren M Tanabe, Stephanie Jou, Frank Chi, William T Dauer.   

Abstract

Lack of a preclinical model of primary dystonia that exhibits dystonic-like twisting movements has stymied identification of the cellular and molecular underpinnings of the disease. The classical familial form of primary dystonia is caused by the DYT1 (ΔE) mutation in TOR1A, which encodes torsinA, AAA⁺ ATPase resident in the lumen of the endoplasmic reticular/nuclear envelope. Here, we found that conditional deletion of Tor1a in the CNS (nestin-Cre Tor1a(flox/-)) or isolated CNS expression of DYT1 mutant torsinA (nestin-Cre Tor1a(flox/ΔE)) causes striking abnormal twisting movements. These animals developed perinuclear accumulation of ubiquitin and the E3 ubiquitin ligase HRD1 in discrete sensorimotor regions, followed by neurodegeneration that was substantially milder in nestin-Cre Tor1a(flox/ΔE) compared with nestin-Cre Tor1a(flox/-) animals. Similar to the neurodevelopmental onset of DYT1 dystonia in humans, the behavioral and histopathological abnormalities emerged and became fixed during CNS maturation in the murine models. Our results establish a genetic model of primary dystonia that is overtly symptomatic, and link torsinA hypofunction to neurodegeneration and abnormal twisting movements. These findings provide a cellular and molecular framework for how impaired torsinA function selectively disrupts neural circuits and raise the possibility that discrete foci of neurodegeneration may contribute to the pathogenesis of DYT1 dystonia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24937429      PMCID: PMC4071385          DOI: 10.1172/JCI72830

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  61 in total

1.  Essential role of synoviolin in embryogenesis.

Authors:  Naoko Yagishita; Kinuko Ohneda; Tetsuya Amano; Satoshi Yamasaki; Akiko Sugiura; Kaneyuki Tsuchimochi; Hiroshi Shin; Ko-Ichi Kawahara; Osamu Ohneda; Tomohiko Ohta; Sakae Tanaka; Masayuki Yamamoto; Ikuro Maruyama; Kusuki Nishioka; Akiyoshi Fukamizu; Toshihiro Nakajima
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

2.  Spatially regulated ubiquitin ligation by an ER/nuclear membrane ligase.

Authors:  Min Deng; Mark Hochstrasser
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

3.  Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Nicole Bode; Beverly L Davidson; Henry L Paulson
Journal:  J Neurosci       Date:  2005-11-09       Impact factor: 6.167

4.  Exploring the influence of torsinA expression on protein quality control.

Authors:  Kara L Gordon; Kevin A Glenn; Pedro Gonzalez-Alegre
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

5.  Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.

Authors:  Gonzalo E Torres; Ava L Sweeney; Jean-Martin Beaulieu; Pullani Shashidharan; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

6.  Printor, a novel torsinA-interacting protein implicated in dystonia pathogenesis.

Authors:  Lisa M Giles; Lian Li; Lih-Shen Chin
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

7.  Interaction of torsinA with its major binding partners is impaired by the dystonia-associated DeltaGAG deletion.

Authors:  Teresa V Naismith; Seema Dalal; Phyllis I Hanson
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

8.  Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.

Authors:  Pedro Gonzalez-Alegre; Henry L Paulson
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

9.  TorsinA and the torsinA-interacting protein printor have no impact on endoplasmic reticulum stress or protein trafficking in yeast.

Authors:  Julie S Valastyan; Susan Lindquist
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

10.  TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton.

Authors:  Flávia C Nery; Juan Zeng; Brian P Niland; Jeffrey Hewett; Jonathan Farley; Daniel Irimia; Yuqing Li; Gerhard Wiche; Arnoud Sonnenberg; Xandra O Breakefield
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

View more
  72 in total

Review 1.  Torsins: not your typical AAA+ ATPases.

Authors:  April E Rose; Rebecca S H Brown; Christian Schlieker
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-10-13       Impact factor: 8.250

Review 2.  Inherited isolated dystonia: clinical genetics and gene function.

Authors:  William Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

4.  Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.

Authors:  Fumiaki Yokoi; Janneth Oleas; Hong Xing; Yuning Liu; Kelly M Dexter; Carly Misztal; Melinda Gerard; Iakov Efimenko; Patrick Lynch; Matthew Villanueva; Raul Alsina; Shiv Krishnaswamy; David E Vaillancourt; Yuqing Li
Journal:  Neurobiol Dis       Date:  2019-10-13       Impact factor: 5.996

5.  TorsinA dysfunction causes persistent neuronal nuclear pore defects.

Authors:  Samuel S Pappas; Chun-Chi Liang; Sumin Kim; CheyAnne O Rivera; William T Dauer
Journal:  Hum Mol Genet       Date:  2018-02-01       Impact factor: 6.150

6.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.

Authors:  Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 7.  Movement disorders in 2014. Genetic advances spark a revolution in dystonia phenotyping.

Authors:  Tom J de Koning; Marina A J Tijssen
Journal:  Nat Rev Neurol       Date:  2015-01-06       Impact factor: 42.937

8.  Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.

Authors:  Mark P DeAndrade; Amy Trongnetrpunya; Fumiaki Yokoi; Chad C Cheetham; Ning Peng; J Michael Wyss; Mingzhou Ding; Yuqing Li
Journal:  Mov Disord       Date:  2016-05-31       Impact factor: 10.338

9.  LINCing defective nuclear-cytoskeletal coupling and DYT1 dystonia.

Authors:  Cosmo A Saunders; G W Gant Luxton
Journal:  Cell Mol Bioeng       Date:  2016-02-03       Impact factor: 2.321

Review 10.  Defining research priorities in dystonia.

Authors:  Codrin Lungu; Laurie Ozelius; David Standaert; Mark Hallett; Beth-Anne Sieber; Christine Swanson-Fisher; Brian D Berman; Nicole Calakos; Jennifer C Moore; Joel S Perlmutter; Sarah E Pirio Richardson; Rachel Saunders-Pullman; Laura Scheinfeldt; Nutan Sharma; Roy Sillitoe; Kristina Simonyan; Philip A Starr; Anna Taylor; Jerrold Vitek
Journal:  Neurology       Date:  2020-02-25       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.